Laiminga uodega - Company finances
|
EUR
|
2021
From: 2021-11-22
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 13,141 | 53,532 | 114,268 | 221,722 |
| Profit before tax | -45 | -9,550 | -1,923 | 1,653 | 7,796 |
| Net profit | -45 | -9,550 | -1,923 | 1,628 | 7,655 |
| Equity | -35 | -9,585 | -11,508 | -9,879 | 5,775 |
| Liabilities | 1,645 | 18,832 | 22,745 | 25,150 | 24,671 |
| Non-current assets | 0 | 11,823 | 9,516 | 7,210 | 4,904 |
| Current assets | 10,995 | 7,241 | 9,232 | 13,265 | 28,417 |
| Total assets | 10,995 | 19,064 | 18,748 | 20,475 | 33,321 |
|
Taxes paid
|
|||||
| STI taxes | - | - | - | 3,757 | 7,532 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +307.4% | +113.5% | +94.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.4% | -50.1% | -10.3% | 8.0% | 23.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 132.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -72.7% | -3.6% | 1.4% | 3.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -72.7% | -3.6% | 1.4% | 3.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 4.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laiminga uodega - Social security debts
The company had no debts to Sodra
Laiminga uodega - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-02 | 2025-03-03 | 0.03 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laiminga uodega, MB (code 305941359) is a small partnership engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €221.7K, up 94.0% year on year and 314.2% over two years. Net profit reached €7.7K, compared with €1.6K in 2024 and a loss of €1.9K in 2023, showing a clear improvement in profitability. The profit margin increased to 3.5% in 2025 from 1.4% in 2024 and -3.6% in 2023. The balance sheet also strengthened: total assets rose to €33.3K, equity turned positive at €5.8K, and liabilities stood at €24.7K. Short-term assets increased to €28.4K, while long-term assets were €4.9K. The company reported an equity ratio of 17.3%, debt-to-equity of 4.27, and asset turnover of 6.65x. Return indicators were strong in 2025, reflecting a higher level of profit relative to the equity base and assets.